Conivaptan Hydrochloride, identified by CAS number 168626-94-6, is a complex organic molecule with a significant role in pharmaceutical chemistry. Its molecular structure, characterized by the chemical formula C32H26N4O2.HCl, endows it with specific pharmacological properties. As a non-peptide antagonist of arginine vasopressin (AVP) receptors, it is primarily recognized for its therapeutic applications in managing hyponatremia. However, its utility extends beyond direct clinical use, positioning it as a vital pharmaceutical intermediate for advanced therapies.

The synthesis and purification of Conivaptan Hydrochloride are critical processes that NINGBO INNO PHARMCHEM CO.,LTD. meticulously oversees. Achieving a high purity level, typically exceeding 98%, is essential for its reliable performance in research and development, as well as in the manufacturing of final drug products. Its application as a fine chemical in creating novel therapeutic agents underscores the importance of consistent quality and precise chemical specifications. The pursuit of the best price and purchase options for such intermediates is a key consideration for pharmaceutical companies.

Beyond its established use in hyponatremia treatment, Conivaptan Hydrochloride is being investigated for its potential in other medical arenas. Emerging research suggests its involvement in pathways related to ischemic stroke and cerebral edema, indicating a broader therapeutic scope. This makes it an attractive compound for drug discovery efforts targeting complex physiological processes. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting these research endeavors by providing a dependable source of this crucial chemical intermediate.

The scientific community relies on the consistent availability of high-quality pharmaceutical intermediates like Conivaptan Hydrochloride to drive innovation. By understanding the chemical properties and potential applications of compounds such as Conivaptan Hydrochloride, NINGBO INNO PHARMCHEM CO.,LTD. aims to be a premier supplier, facilitating the development of next-generation pharmaceuticals.